Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists.
Mohanty SK, Lobo A, Jha S, Sangoi AR, Akgul M, Trpkov K, Hes O, Mehra R, Hirsch MS, Moch H, Smith SC, Shah RB, Cheng L, Amin MB, Epstein JI, Parwani AV, Delahunt B, Desai S, Przybycin CG, Manini C, Luthringer DJ, Sirohi D, Jain D, Midha D, Jain E, Maclean F, Giannico GA, Paner GP, Martignoni G, Al-Ahmadie HA, McKenney J, Srigley JR, Lopez JI, Kunju LP, Browning L, Aron M, Picken MM, Tretiakova M, Zhou M, Sable M, Kuroda N, Pattnaik N, Gupta NS, Rao P, Fine SW, Mishra P, Adhya AK, Kulkarni BN, Dixit M, Baisakh MR, Arora S, Sancheti S, Menon S, Wobker SE, Tickoo SK, Kaushal S, Soni S, Kandukuri S, Sharma S, Mitra S, Reuter VE, Malik V, Rao V, Chen YB, Williamson SR. Mohanty SK, et al. Among authors: wobker se. Virchows Arch. 2024 Sep 17. doi: 10.1007/s00428-024-03909-2. Online ahead of print. Virchows Arch. 2024. PMID: 39287823
Associations of prostate tumor immune landscape with vigorous physical activity and prostate cancer progression.
Huang L, Winter SJ, Olsson LT, Hamilton AM, Halliday SR, Kirk EL, Farnan L, Gerstel A, Craig SG, Finn SP, LaBonte Wilson M, Jain S, Troester MA, Butler EN, Bensen JT, Wobker SE, Allott EH. Huang L, et al. Among authors: wobker se. Cancer Epidemiol Biomarkers Prev. 2024 Sep 13. doi: 10.1158/1055-9965.EPI-24-0263. Online ahead of print. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 39269980
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features.
Wijetunga NA, Gessner KH, Kanchi K, Moore JA, Fleischmann Z, Jin DX, Frampton GM, Sturdivant M, Repka M, Sud S, Corcoran DL, Galsky MD, Milowsky MI, Wobker SE, Kim WY, Rose TL, Damrauer JS. Wijetunga NA, et al. Among authors: wobker se. Cancer Res Commun. 2024 Sep 1;4(9):2320-2334. doi: 10.1158/2767-9764.CRC-24-0352. Cancer Res Commun. 2024. PMID: 39113632 Free PMC article.
Visual Intratumor Heterogeneity and Breast Tumor Progression.
Li Y, Van Alsten SC, Lee DN, Kim T, Calhoun BC, Perou CM, Wobker SE, Marron JS, Hoadley KA, Troester MA. Li Y, et al. Among authors: wobker se. Cancers (Basel). 2024 Jun 21;16(13):2294. doi: 10.3390/cancers16132294. Cancers (Basel). 2024. PMID: 39001357 Free PMC article.
Ensuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer.
McConkey DJ, Baumann BC, Cooper Greenberg S, DeGraff DJ, Delacroix SE, Efstathiou JA, Foster J, Groshen S, Kadel EE, Khani F, Kim WY, Lerner SP, Levin T, Liao JC, Milowsky MI, Meeks JJ, Miyamoto DT, Mouw KW, Pietzak EJ, Solit DB, Sundi D, Tawab-Amiri A, West PJ, Wobker SE, Wyatt AW, Apolo AB, Black PC. McConkey DJ, et al. Among authors: wobker se. Bladder Cancer. 2024 Mar 12;10(1):1-8. doi: 10.3233/BLC-230082. eCollection 2024. Bladder Cancer. 2024. PMID: 38993535 Free PMC article. No abstract available.
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer.
Beckabir W, Zhou M, Lee JS, Vensko SP, Woodcock MG, Wang HH, Wobker SE, Atassi G, Wilkinson AD, Fowler K, Flick LM, Damrauer JS, Harrison MR, McKinnon KP, Rose TL, Milowsky MI, Serody JS, Kim WY, Vincent BG. Beckabir W, et al. Among authors: wobker se. Nat Commun. 2024 May 24;15(1):4448. doi: 10.1038/s41467-024-48480-1. Nat Commun. 2024. PMID: 38789460 Free PMC article. Clinical Trial.
67 results